About this Disease
Esophageal cancer research continues to advance our understanding of the disease, from prevention and early detection to diagnosis, surgery, systemic therapies, and survivorship. ECEF has created this resource library to help patients, caregivers, families, and the broader community explore current articles and research on esophageal cancer treatment, clinical studies, surgical advances, immunotherapy, targeted therapies, biomarkers, screening, risk factors, and emerging approaches to care. Articles are selected from external medical, research, and news sources and link to the original publication for further reading.
Showing 20 of 1377 resources
Lung and Esophageal Cancer: Screening, Surgical Advances, Robotics and Post-operative Rehabilitation
Lung and esophageal cancers remain among the most lethal thoracic malignancies, largely because both present late. The last decade has shifted the balance in th
Ask the doctors: Symptoms of esophageal cancer can be easy to dismiss
An Ask the Doctors column explains risk factors for esophageal cancer and why persistent symptoms such as swallowing difficulty, heartburn, hoarseness, choking, and unexplained weight loss warrant medical attention.
FDA Approves New First-Line Treatment Options for HER2-Positive AdvancedGastric and GEJ Cancer – CancerConnect
The FDA has approved new first-line zanidatamab-based treatment options for certain people with HER2-positive advanced stomach, gastroesophageal junction, and esophageal cancers. In a major clinical trial, the combination of zanidatamab, tislelizumab, and chemotherapy extended survival…
What Is Difference between Asthma and GERD? Dr. Badran Answers | Sada Elbalad
What Is Difference between Asthma and GERD? Dr. Badran Answers
The Bill Reddig Foundation for Esophageal Cancer Raises Nearly $7,000 for ECEF
The Bill Reddig Foundation for Esophageal Cancer Raises Nearly $7,000 for ECEF. Centennial-Based Non-Profit Exceeds Fundraising Goals Following its First Event Held in Honor of Local Esophageal Cancer Survivor Bill Reddig – PR11865056
Predicting Tumor Response Using Combo of Peritumoral Radiomics Features Appears Effective
A combination of peritumoral radiomics features appeared to improve the predictive performance of intratumoral radiomics to estimate pathological complete response after neoadjuvant chemoradiation in patients with esophageal squamous cell carcinoma. https://www.cancernetwork.com/view/predicting-tumor-response-using-combo-of-peritumoral-radiomics-features-appears-effective
Study Shows Nivolumab-Chemo Combination Improves Survival in Gastric and Esophageal Cancers
Bristol Myers Squibb announced that their phase 3 CheckMate-649 trial demonstrated superior overall survival and profession-free survival using nivolumab plus chemotherapy to treat patients with gastric and esophageal cancers. https://www.cancernetwork.com/view/study-shows-nivolumab-chemo-combination-improves-survival-in-gastric-and-esophageal-cancers
Interleukin Inhibitors May Raise Infection, Cancer Risks
Treatment of rheumatologic diseases with interleukin inhibitors may raise patients’ risks for serious and opportunistic infections and possibly also cancer, researchers reported in JAMA Network Open in October. https://www.rheumatologynetwork.com/news/interleukin-inhibitors-may-raise-infection-cancer-risks
Current Treatment of Esophageal Cancer and Promising Clinical Trials Underway
To discuss current and emerging therapy options for esophageal cancer, ONCOLOGY spoke with Geoffrey Y. Ku, MD, a medical oncologist at Memorial Sloan Kettering Cancer Center in New York, who specializes in the treatment of…
Endoscopic Resection Brings Excitement to Esophageal Cancer Treatment
Cancer Network spoke with Dr. Daniela Molena about the advancements in the treatment of esophageal cancer, including the safety and importance of endoscopic resection for the disease. http://www.cancernetwork.com/asco-gi-street-team/endoscopic-resection-brings-excitement-esophageal-cancer-treatment
Chemotherapy Toxicity Differs by Sex in Esophageal Cancer
A large pooled analysis of individuals with advanced esophageal cancer showed men and women have different side effects to chemotherapy. Further exploration of these findings could help inform treatment decisions to include certain medications to…
Is Controversy Over NCRT Plus Surgery Warranted in Esophageal Squamous Cell Carcinoma?
Neoadjuvant chemoradiotherapy (NCRT) plus surgery significantly improves survival vs surgery alone in locally advanced esophageal squamous cell carcinoma (ESCC), with acceptable and manageable adverse events, according to a new study. http://www.cancernetwork.com/head-neck-cancer/controversy-over-ncrt-plus-surgery-warranted-esophageal-squamous-cell-carcinoma